| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/23/2009 | US20090104198 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
| 04/23/2009 | US20090104182 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 04/23/2009 | US20090104150 Polymer conjugates of interferon Beta-1a and uses |
| 04/23/2009 | US20090104121 Multi-subunit biological complexes for treatment of plaque-associated diseases |
| 04/23/2009 | CA2704201A1 Novel sulfated oligosaccharide derivatives |
| 04/23/2009 | CA2702745A1 Trisubstituted piperidines |
| 04/23/2009 | CA2702699A1 Csf-1r inhibitors compositions, and mthods of use |
| 04/23/2009 | CA2702644A1 A3 adenosine receptor antagonists |
| 04/23/2009 | CA2702468A1 Therapeutic applications of fatty acid amide hydrolase inhibitors |
| 04/23/2009 | CA2702378A1 Novel patient subgroups for thrombolysis |
| 04/23/2009 | CA2702011A1 Composition for regulating lipid metabolism |
| 04/23/2009 | CA2700243A1 New no-donor aspirin derivatives |
| 04/23/2009 | CA2699075A1 Use of a peptide as a therapeutic agent |
| 04/22/2009 | EP2050762A2 Novel polypeptides and nucleic acids encoding the same |
| 04/22/2009 | EP2050751A1 Compounds specific to adenosine A1 and A3 receptors and uses thereof |
| 04/22/2009 | EP2050750A2 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
| 04/22/2009 | EP2050744A1 Quinazoline derivatives as angiogenesis inhibitors |
| 04/22/2009 | EP2050741A1 Crystalline polymorphism of 5-methyl-2-(piperazin-1-yl)benzenesulfonic acid |
| 04/22/2009 | EP2050739A1 Quinazoline derivative |
| 04/22/2009 | EP2050468A1 Agent for treatment of cerebral ischemic diseases |
| 04/22/2009 | EP2050462A1 Improved treatment of stroke patients |
| 04/22/2009 | EP2050450A1 1-Piperidine-2-cyanoimino-1,3-dihydro-2H-benzimidazole derivatives as nociceptin analogs with ORL1 modulating activity for the treatment of pain |
| 04/22/2009 | EP2049517A1 Amino-piperidine derivatives as cetp inhibitors |
| 04/22/2009 | EP2049515A2 Triazolyl pyridyl benzenesulfonamides as ccr2 or ccr9 modulators for the treatment of atherosclerosis |
| 04/22/2009 | EP2049514A1 Nitrate esters of piperidines |
| 04/22/2009 | EP2049510A1 Process for the preparation of candesartan cilexetil form i |
| 04/22/2009 | EP2049484A1 Isoindoline derivatives for the treatment of arrhythmias |
| 04/22/2009 | EP2049141A1 Treatment for intimal hyperplasia and related conditions |
| 04/22/2009 | EP2049127A2 N-methanocarba derivatives to treat cardiac diseases |
| 04/22/2009 | EP2049122A1 Methods and compositions for inhibiting angiogenesis |
| 04/22/2009 | EP2049120A1 Urotensin ii receptor antagonists |
| 04/22/2009 | EP2049007A1 Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects |
| 04/22/2009 | EP1718328B1 Use of factor xiii for stimulating the perfusion of ischemic tissue |
| 04/22/2009 | EP1567176B1 An anti-arrhythmic compound from king cobra venom and a process of purification thereof |
| 04/22/2009 | EP1551865B1 Hybrid molecules of macrolides with steroidal/non-steroidal anti-inflammatory molecules |
| 04/22/2009 | EP1515704B1 Microcapsules for the delayed, controlled release of perindopril |
| 04/22/2009 | EP1507529B1 Combination comprising valsartan, amlodipine and hydrochlorothiazide |
| 04/22/2009 | EP1364069B1 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes |
| 04/22/2009 | EP1285908B9 Substituted phenylpropionic acid derivatives |
| 04/22/2009 | CN101415716A Condensed imidazole derivatives as aldosterone synthase inhibitors |
| 04/22/2009 | CN101415703A Substituted 4-phenyl piperidines for use as renin inhibitors |
| 04/22/2009 | CN101415690A Novel tricyclic dihydropyrazines as potassium channel openers |
| 04/22/2009 | CN101415418A Agent exhibiting a neurotropic, neuromodulator, cerebrovascular and anti- stroke activity |
| 04/22/2009 | CN101415413A Renin inhibitors for the treatment of hypertension |
| 04/22/2009 | CN101413143A Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 04/22/2009 | CN101412726A Novel heterocyclic compounds |
| 04/22/2009 | CN101412711A Carbamate derivatives and use thereof in medicine |
| 04/22/2009 | CN101412687A Preparation of optically-active pure ibutilide fumarate |
| 04/22/2009 | CN101411852A Capsule containing hooked uncaria and gastrodia |
| 04/22/2009 | CN101411851A Chinese medicinal composition for preventing and treating hyperlipemia symptom and atherosclerosis |
| 04/22/2009 | CN101411850A Chinese medicinal composition for treating cerebral apoplexy or cerebroma, Chinese medicament preparation, and preparation method thereof |
| 04/22/2009 | CN101411846A Chinese medicine for tonifying kidney, resolving stasis, softening pulse and strengthening brain |
| 04/22/2009 | CN101411833A Dragon's blood extract as well as preparation method and application thereof |
| 04/22/2009 | CN101411828A External use medicament for treating varicose vein of lower limb |
| 04/22/2009 | CN101411827A Internal medicament for treating varicose vein of lower limb |
| 04/22/2009 | CN101411821A Anti-aging medicament for treating coronary heart disease and hyperlipemia, and preparation method thereof |
| 04/22/2009 | CN101411814A Use of Chinese medicinal composition in preparing medicament for treating intraventricular block |
| 04/22/2009 | CN101411810A Medicament for treating multiple sclerosis symptoms |
| 04/22/2009 | CN101411770A Medicament for treating blood stasis accumulation type multiple sclerosis symptoms |
| 04/22/2009 | CN101411767A Medicament formulation containing garden burnet and pagodatree fruit as well as method for preparing the same |
| 04/22/2009 | CN101411764A Use of Chinese medicinal composition in preparing medicament for treating degenerative cardiac valve disease of old age |
| 04/22/2009 | CN101411747A Salvia root polyphenol acid orally disintegrating tablets and preparation method thereof |
| 04/22/2009 | CN101411746A Novel use of salvia root extract |
| 04/22/2009 | CN101411742A Capsule for freeing collateral vessels containing astragalus and leech |
| 04/22/2009 | CN101411740A Dropping pills for treating cardiovascular disease and preparation method thereof |
| 04/22/2009 | CN101411737A Safflower injection formulation and preparation method thereof |
| 04/22/2009 | CN101411736A Use of chicory extract in preparing novel medicament for treating ischemic cardio-cerebrovascular disease |
| 04/22/2009 | CN101411735A Quality control method of pharmaceutical composition for preventing and treating coronary heart disease |
| 04/22/2009 | CN101411732A Hypericuin perforatum L. extract as well as preparation method and application thereof |
| 04/22/2009 | CN101411728A Shuxuening injection formulation and preparation method thereof |
| 04/22/2009 | CN101411713A Compound Nimodipine tablet, and enteric tablet thereof, as well as preparation method thereof |
| 04/22/2009 | CN101411712A 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 04/22/2009 | CN101411711A Composition containing alisol A and alisol A 24-acetic ester and use |
| 04/22/2009 | CN101411709A Use of Nifekalant |
| 04/22/2009 | CN101411708A Stable Levosimendan pharmaceutical composition and preparation method thereof |
| 04/22/2009 | CN101411705A Pharmaceutical composition for preventing and treating atherosclerosis |
| 04/22/2009 | CN101411703A Medicinal composition for treating angiocardiopathy |
| 04/22/2009 | CN101411698A Use of salvia root salvianolic acid A |
| 04/22/2009 | CN101411697A Medicinal composition for treating angiocardiopathy |
| 04/22/2009 | CN101411532A Beverage containing natural medicament leaf of Toxicodendron vernicifluum and sealwort compositions and preparation method thereof |
| 04/22/2009 | CN101411497A Lipid-lowering pressure-reducing hypoglycemic health tea |
| 04/22/2009 | CN100480699C Method of preparing medication for treating cardiovascular diseases, and method for controlling quality |
| 04/22/2009 | CN100480387C GBS toxin receptor |
| 04/22/2009 | CN100480375C Human cord blood derived unrestricted somatic stem cells (USSC) |
| 04/22/2009 | CN100480266C Interferon-beta fusion proteins and uses |
| 04/22/2009 | CN100480253C Alkylamino alkoxyl substituted C-glycosylisoflavones and preparing method and the use of the same |
| 04/22/2009 | CN100480249C Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase |
| 04/22/2009 | CN100480245C 2-amino-4H-3.1-benzoxazinone-4-keto derivatives for treatment of obesity |
| 04/22/2009 | CN100480242C CDK-inhibitory pyrimidines, and production and use thereof as pharmaceutical agents |
| 04/22/2009 | CN100480241C Kukoline C ring modified derivative and synthesis method thereof |
| 04/22/2009 | CN100479930C Biological control of nanoparticles |
| 04/22/2009 | CN100479862C Transporters and drug delivery system by using the same |
| 04/22/2009 | CN100479842C Medicine for treating arrhythmia and preparation method thereof |
| 04/22/2009 | CN100479837C Weinakang for treating ischemic cerebrovascular disease and senile dementia and preparation method thereof |
| 04/22/2009 | CN100479836C Use of Tibet picrorhiza rhizome in preparation of medicine for treating atherosclerosis |
| 04/22/2009 | CN100479834C Method for processing monkshood |
| 04/22/2009 | CN100479833C Extraction method of polygala refined total saponin |
| 04/22/2009 | CN100479831C Compositions for preventing or ameliorating multiple risk factor syndromes |
| 04/21/2009 | US7521566 N-[(S)-1-carbethoxybutyl]-(S)-alanine carboxylic acid halide is reacted with benzyl ester of (2S, 3aS, 7aS)-2-carboxyperhydroindole, followed by catalytic hydrogenation to give perindopril |
| 04/21/2009 | US7521455 Histamine H3 receptor antagonist or inverse agonist activity; metabolic diseases, circulatory diseases, or nervous system diseases; e.g. 3-(4-((1-cyclobutyl-4-piperidinyl)oxy)phenyl)-2-ethylpyrido(2,3-d)pyrimidin-4(3H)-one |